Assyro AI

FDA Orange Book · active-ingredient family

Enalapril maleate

Enalapril maleate is approved as 3 brand and 23 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:EPANED · NDA 208686

3

Brand (NDA)

23

Generics (ANDA)

13

Listed patents

0

Exclusivity periods

Brand (NDA) products · for solution, solution, tablet

ProductApplicantApplicationTEApproved
EPANEDRLDAZURITYNDA 208686ABSep 20, 2016
EPANED KITRLDAZURITYNDA 204308Aug 13, 2013
VASOTECRLD×4BAUSCHNDA 018998ABJul 26, 1988

Generic (ANDA) products (23)

ProductApplicantApplicationTEApproved
ENALAPRIL MALEATE×4UNIQUE PHARMANDA 218531ABSep 19, 2024
ENALAPRIL MALEATEAUROBINDO PHARMAANDA 216458ABJan 08, 2024
ENALAPRIL MALEATE×4PRINSTON INCANDA 213273ABJul 07, 2022
ENALAPRIL MALEATEAMNEALANDA 212894ABJun 29, 2022
ENALAPRIL MALEATEALKEM LABS LTDANDA 213714ABMar 30, 2022
ENALAPRIL MALEATEANNORA PHARMAANDA 214467ABFeb 24, 2022
ENALAPRIL MALEATEBIONPHARMAANDA 212408ABAug 10, 2021
ENALAPRIL MALEATE×4AIPING PHARM INCANDA 075178ABMar 23, 2001
ENALAPRIL MALEATE×4TAROANDA 075657ABJan 23, 2001
ENALAPRIL MALEATE×4APOTHECONANDA 075583Aug 22, 2000
ENALAPRIL MALEATE×4AUROBINDO PHARMA USAANDA 075480Aug 22, 2000
ENALAPRIL MALEATE×4CHARTWELL RXANDA 075048Aug 22, 2000
ENALAPRIL MALEATE×4HERITAGE PHARMAANDA 075479ABAug 22, 2000
ENALAPRIL MALEATE×4IVAX SUB TEVA PHARMSANDA 075482Aug 22, 2000
ENALAPRIL MALEATE×2KRKA DD NOVO MESTOANDA 075370Aug 22, 2000
ENALAPRIL MALEATE×2KRKA DD NOVO MESTOANDA 075369Aug 22, 2000
ENALAPRIL MALEATE×4MYLANANDA 075472Aug 22, 2000
ENALAPRIL MALEATE×4REGCON HOLDINGSANDA 075621Aug 22, 2000
ENALAPRIL MALEATE×2SANDOZ INCANDA 075496ABAug 22, 2000
ENALAPRIL MALEATE×2SANDOZ INCANDA 075459ABAug 22, 2000
ENALAPRIL MALEATE×4SENORES PHARMSANDA 075483ABAug 22, 2000
ENALAPRIL MALEATE×4SUN PHARM INDS LTDANDA 075556Aug 22, 2000
ENALAPRIL MALEATE×4WATSON LABSANDA 075501Aug 22, 2000

Listed patents (13)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8778366Nov 06, 2032in 6 yr 6 mo
U-3
9968553Nov 06, 2032in 6 yr 6 mo
U-71
8568747Nov 06, 2032in 6 yr 6 mo
Product
9855214Nov 06, 2032in 6 yr 6 mo
Product
9808442Mar 25, 2036in 9 yr 11 mo
U-71
10154987Mar 25, 2036in 9 yr 11 mo
U-3
11040023Mar 25, 2036in 9 yr 11 mo
Product
9669008Mar 25, 2036in 9 yr 11 mo
Product
10772868Mar 25, 2036in 9 yr 11 mo
Product
10786482Mar 25, 2036in 9 yr 11 mo
Product
10039745Mar 25, 2036in 9 yr 11 mo
Product
11173141Mar 25, 2036in 9 yr 11 mo
Product
11141405Mar 25, 2036in 9 yr 11 mo
Product

Enalapril maleate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.